menu
    • menu

    Company profile for Senti Biosciences

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Senti is a technology-driven therapeutics company here to lead the next generation of medicine—where cells are the hardware and gene circuits are the software. Programming cells to respond, adapt and make decisions, Senti is working to create smarter therapies with computer-like logic, enhanced functionality and greater control.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Senti BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Corporate Drive, First Floor South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sentibio.com/
    Linkedin
    Linkedin
    https://www.sentibio.com/application/files/9115/5303/9148/footer-linkedin-icon.png
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/sentibio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senti Bio Announces SENTI-202's MRD-Negative AML Remissions
    Senti Bio Announces SENTI-202's MRD-Negative AML Remissions

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202225/0/en/Senti-Bio-Announces-Updated-SENTI-202-Clinical-Data-from-Ongoing-Phase-1-Trial-in-Relapsed-or-Refractory-Acute-Myeloid-Leukemia-Patients-Demonstrating-Deep-MRD-Negative-Durable-Com.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Senti Bio Secures FDA RMAT for SENTI-202 in R/R AML
    Senti Bio Secures FDA RMAT for SENTI-202 in R/R AML

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202222/0/en/Senti-Bio-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-SENTI-202-in-the-Treatment-of-Adults-with-Relapsed-or-Refractory-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Senti Bio To Discuss SENTI-202 Clinical Data At ASH Meeting 2025
    Senti Bio To Discuss SENTI-202 Clinical Data At ASH Meeting 2025

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199813/0/en/Senti-Bio-to-Host-Conference-Call-and-Webcast-to-Discuss-SENTI-202-Clinical-Data-Being-Presented-at-the-American-Society-of-Hematology-ASH-Annual-Meeting-2025-on-Tuesday-December-9.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Senti Bio Confirms Phase 1 SENTI-202 (AML) Data Readout at ASH
    Senti Bio Confirms Phase 1 SENTI-202 (AML) Data Readout at ASH

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187887/0/en/Senti-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Confirms-Next-Clinical-Data-Readout-for-Phase-1-SENTI-202-Study-in-Acute-Myeloid-Leukemia-AML-at-the-American-Society-of-.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Senti Bio To Unveil SENTI-202, Clinical Data at ASH 2025
    Senti Bio To Unveil SENTI-202, Clinical Data at ASH 2025

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179400/0/en/Senti-Bio-to-Present-Updated-Clinical-Results-of-First-in-Class-Logic-Gated-CD33-FLT3-Cell-Therapy-SENTI-202-at-the-American-Society-of-Hematology-ASH-Annual-Meeting-2025.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Senti Bio To Present At Chardan's Genetic Medicines Conference
    Senti Bio To Present At Chardan's Genetic Medicines Conference

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167985/0/en/Senti-Bio-to-Present-at-Chardan-s-9th-Annual-Genetic-Medicines-Conference.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search